Core Viewpoint - The article highlights various high-paying job opportunities in the scientific instrument sector, emphasizing the demand for skilled sales and technical support professionals in this industry [2][14][20]. Group 1: Sales Positions - Agilent Technologies (China) is hiring a Channel Sales Manager in Beijing with a salary range of 18k-28k, requiring 3-5 years of channel management experience [2]. - OsiSense (Beijing) is looking for a Key Account Sales Manager with a salary range of 20k-30k, requiring experience in B2B large project sales [3]. - Shanghai Kezhe Biochemical Technology is seeking an Automation Project Sales Manager in Shanghai with a salary range of 13k-22k, requiring over 3 years of relevant experience [4]. Group 2: Technical Support and After-Sales Positions - Labtech is hiring a Mass Spectrometry Maintenance Engineer in Guangzhou with a salary range of 10k-12k, requiring at least 1 year of experience with ICPMS [14]. - Shanghai Linli Instrument Co. is looking for an Inorganic Analysis After-Sales Engineer with a salary range of 10k-30k, requiring over 2 years of relevant experience [16]. - Beijing Jingwei Gaobo Instrument Co. is seeking a Technical Support Engineer in Beijing with a salary range of 8k-20k, requiring a background in chemistry or materials [17]. Group 3: Regional Sales Positions - Liaoning Jiahua International Trade is hiring an Instrument Sales Engineer for the Panjin region, requiring at least 2 years of chromatography and spectroscopy sales experience [7]. - DCH Science Instrument Department is looking for a Regional Sales Manager in Beijing, requiring over 3 years of sales experience in materials science or chemical analysis [8]. - Hangzhou Puyue Technology Development is seeking a Regional Sales Manager for laboratories in Chengdu with a salary range of 8k-15k, requiring knowledge of chromatography/spectroscopy [10][11].

Core Viewpoint - The domestic scientific instrument industry in China experienced 40 disclosed financing events in the first half of 2025, nearly unchanged from the same period in 2024, indicating a stable investment environment. The current investment trend is shifting towards "scenario-based application implementation" alongside "domestic substitution" and "key technology breakthroughs" [1] Group 1: Financing Events and Trends - In the first half of 2025, there were 40 financing events in the domestic scientific instrument industry, showing stability compared to 2024 [1] - The investment focus is evolving towards "scenario-based application implementation," highlighting a new trend in the industry [1] Group 2: Key Laboratory Recognition in Zhejiang - The Zhejiang Provincial Science and Technology Department announced the recognition of 8 key laboratories led by universities and research institutes in Wenzhou for 2024, contributing to a total of 16 key laboratories in the city, ranking third in the province [2] - The recognized laboratories cover various fields, including intelligent control, new drug development, advanced medical devices, functional materials, fine chemicals, and carbon neutrality technologies [3] Group 3: Research and Development Initiatives - Wenzhou is enhancing its high-level scientific innovation platforms, with 3 provincial-level new research and development institutions leading the establishment of key laboratories [3] - The city aims to leverage these laboratories to achieve internationally influential original results and address critical core technology issues, thereby supporting local economic development [4]

导读： 本文以国内50家上市仪器公司为研究对象，深入剖析研发与销售员工薪酬情况，为您揭开仪器行 业人才竞争的真实面纱。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 6 月 14 日 上 午 ， 首 届 全 国 大 学 生 科 学 仪 器 创 新 大 赛 启 动 仪 式 在 北 京 航 空 航 天 大 学 校 友 之 家 举 办。本次大赛由中国仪器仪表学会、北京航空航天大学、北京市科学技术委员会、中关村科技 园区管理委员会、中关村科学城管理委员会和中关村发展集团共同主办，由北京中关村集成电 路设计园发展有限责任公司、北京航空航天大学集成电路科学与工程学院、北京新材料和新能 源科技发展中心承办，旨在挖掘大学生在科学仪器领域的创新能力，激发大学生科研与创业热 情，培育一批以大学生为主体的活力足、技术特点鲜明的青年人才队伍与初创企业。本次启动 仪式，来自政府、高校和科研院所的领导、专家和学者、合作伙伴等共100余人到场见证。 北航副校长赵巍胜指出，国产高端科学仪器的广泛使用是建设科技强国的基本特征，北航始终 坚持以服务国家战略需求为导向，致力 ...

Core Insights - The domestic scientific instrument industry experienced 40 financing events in the first half of 2025, maintaining a level similar to the same period in 2024, indicating a stable investment climate [1][3] - The current investment trend is shifting towards "scene-based application landing," alongside a focus on "domestic substitution" and "key technology breakthroughs" [1][14] Financing Overview - In the first half of 2025, significant financing events included Tongjia Hongrui, a semiconductor equipment service provider, which completed a B round financing of nearly 500 million yuan, marking the highest single financing amount during this period [3][5] - Notable companies like Miaoshun Bio and Chuguang 3D completed multiple financing rounds, with the latest rounds involving equity changes [3][4] Regional Distribution - The Yangtze River Delta region leads in financing activities, accounting for 48.72% of the total, benefiting from a robust research foundation and mature industrial ecosystem [6] - Among disclosed financing projects, 20.51% involved amounts exceeding 10 million yuan, while 43.59% were over 100 million yuan, indicating a healthy distribution of investment [6] Sector Highlights - In the chromatography and mass spectrometry sector, companies like Huapu Instrument and Yilite Technology have made significant strides, with Huapu securing over 100 million yuan for next-generation product development [8][9] - The life sciences instrument sector remains a hotbed for financing, with 15 companies receiving funding in the first half of 2025, reflecting strong investor confidence in domestic innovation [11][12] Emerging Growth Areas - The semiconductor testing, optical measurement, and sensor systems sectors have also shown robust financing activity, with over 10 events recorded [13] - Tongjia Hongrui's 500 million yuan financing will focus on vacuum system solutions and talent acquisition, reinforcing its market position [13] Investment Trends - The current investment landscape is characterized by a preference for projects with clear market applications and the potential for rapid industrial closure, moving away from solely technology-driven innovations [14] - The integration of AI, automation, and intelligent analysis is becoming a new engine for industry innovation, indicating a shift towards a more integrated approach in the scientific instrument sector [14]

Core Viewpoint - The 2024 global CEO compensation ranking for scientific instrument companies reveals that Thermo Fisher's CEO tops the list with a salary exceeding 200 million yuan, amidst a backdrop of declining industry net profits and a growing focus on the linkage between executive pay and company performance [1][2]. Summary by Sections CEO Compensation Rankings - The ranking includes 13 multinational instrument companies, with Thermo Fisher's CEO Marc N. Casper earning 30.45 million USD, a 60.4% increase from the previous year. Other notable compensations include Danaher's Rainer M. Blair at 22.11 million USD and Agilent's Padraig McDonnell at 9.04 million USD [3][6]. - Five CEOs have annual salaries exceeding 10 million USD, with Thermo Fisher, Danaher, Agilent, Illumina, and AMETEK leading the list [6]. Industry Performance - The overall industry faced challenges, with many companies experiencing reduced profits and increased costs. Only five out of the 13 companies reported year-over-year net profit growth [6][9]. - The average net profit margin for the industry decreased from 15.7% in 2023 to 11.6% in 2024, reflecting a slowdown in industry growth [11]. CEO Pay and Company Performance - The compensation of CEOs is closely tied to company performance, with only three CEOs seeing a decrease in pay. Notably, Illumina's CEO saw a 215.5% increase in compensation despite a decline in company revenue and net profit [6][9]. - The ratio of CEO compensation to net profit varies, with the highest being 5.02% for Bio-Rad's CEO, while Thermo Fisher's CEO has the lowest at 0.48% [9]. Gender Representation - Veralto's CEO Jennifer L. Honeycutt is the only female CEO in the ranking, earning 11.53 million USD, a 22.8% increase from the previous year [8]. Executive Pay Structure - The article discusses the necessity of linking executive pay to company performance, emphasizing that high compensation should be justified by superior company results to align the interests of executives and shareholders [10][11].

Core Viewpoint - The article emphasizes the acceleration of domestic research instrument development and validation in Jiangsu to gain control over technological innovation amid increasing competition in the tech sector [1]. Group 1: Event and Activity Summary - A promotional event is being held to thank users of the instrument information network, offering rewards of 5-15 yuan in JD E-cards for participating in instrument selection and procurement consultations [2][3]. - The event runs from now until September 30, 2025, targeting end-user buyers such as universities, industrial enterprises, testing institutions, research institutes, and government agencies [3]. - Participants must add a procurement consultant via WeChat and send valid selection and procurement consultation information to qualify for rewards [3][4]. Group 2: Reward Structure - The reward structure includes 5 yuan per valid consultation for consumables, 10 yuan for instrument consultations, and 15 yuan for specified categories and domestic substitution needs [4][5]. - Specific categories eligible for higher rewards include flow cytometers, radiation detectors, pH meters, and various analytical instruments [4][5][6]. Group 3: Service Introduction - "Yicaitong" is introduced as a professional procurement service platform for scientific instruments, designed to address the pain points of procurement personnel regarding expertise and efficiency [7].

Group 1 - The core viewpoint is that despite external pressures, China is accelerating the cultivation of new momentum in AI application scenarios, advanced manufacturing, and consumption upgrades [1] - The recent research direction of the fund aligns with this viewpoint, having conducted surveys on companies like Cangge Mining, Juguang Technology, Ximai Food, and Shengxin Lithium Energy since June [1] - Market data supports the fund's layout logic, with the main product, Siyuan Three-Year Holding Period Mixed A, achieving a nearly one-year return of 10.16% as of June 17, 2025, with the top ten heavy stocks in technology and new energy accounting for 53.37% [1] Group 2 - The fund manager emphasizes that the AI terminal's intelligentization will enter a product explosion cycle by 2025, while lithium battery leaders have begun to recover from the industry bottom [2] - Industry trends are reflected in the upcoming production of Shengxin Lithium Energy's 60,000 tons lithium salt project in Indonesia and Cangge Mining's successful team preparation for lithium extraction technology [2] - The fund currently manages a scale of 17.09 billion yuan and continues to enhance its ability to capture industry trends through research and investment linkage [2]

Core Viewpoint - The article highlights the resilience and innovative vitality of China's scientific instrument industry in the face of global challenges, showcasing significant growth in overseas revenue among domestic listed companies [2][6]. Group 1: Overview of Overseas Revenue - In 2024, the total overseas revenue of 43 domestic listed instrument companies reached 34.707 billion yuan, marking a new high [6][10]. - Over 60% of the companies reported revenue growth, with 21 companies achieving over 100 million yuan in overseas revenue [6][10]. - The top five companies by overseas revenue are Mindray Medical (16.434 billion yuan), Sunny Optical (9.602 billion yuan), Libang Instruments (1.098 billion yuan), BGI Genomics (913 million yuan), and Huashengchang (717 million yuan) [3][6]. Group 2: Performance Analysis - Among the 43 companies, 27 experienced stable or significant growth, with notable examples including Wanyi Technology, which saw a 447.23% increase in overseas revenue [7][12]. - Conversely, 14 companies faced revenue declines, such as Gaode Infrared, which reported a 50.76% drop [7][15]. - Mindray Medical's overseas revenue accounted for 44.75% of its total revenue, reflecting the effectiveness of its globalization strategy [10][17]. Group 3: Market Dynamics - The article indicates a shift in the market, with three companies achieving over 1 billion yuan in overseas revenue, while 18 companies fall within the 100 million to 1 billion yuan range [13]. - Companies with overseas revenue constituting over 10% of total revenue increased to 22, indicating a growing trend in international market engagement [17]. - Wanyi Technology's strategy of "product leadership, quality excellence, competitive pricing, and superior service" has led to substantial growth in overseas markets [13][17]. Group 4: Emerging Companies - New entrants like Titan Technology and Lihua Technology reported 100% growth in overseas revenue, reflecting successful market expansion strategies [14]. - Titan Technology leveraged partnerships with overseas distributors and acquisitions to enhance its competitive brand presence [14]. Group 5: Future Outlook - Despite external uncertainties, the overall trend indicates a robust commitment from Chinese companies to expand in international markets, suggesting a "fast forward" approach to globalization [17].

Core Viewpoint - The development of QY products is a challenging journey, with the reliability of the device being proven over four years from project initiation to paper publication, involving hundreds of experiments, showcasing the engineers' respect for scientific spirit [1]. Group 1: Technical Origins - In April 2000, Suzuki Kengo joined Hamamatsu and embarked on a journey to revolutionize measurement standards in the industry, focusing on optical design despite initial challenges [4]. - Suzuki led the development of the first absolute quantum efficiency testing system, C9920-02, marking the beginning of the application of the "absolute method" [4]. Group 2: Industry-Academic Resonance - The rise of organic EL in 2004 created a demand for measuring the photoluminescence quantum yield (PLQY) of solid-state materials, which traditional methods could not adequately address [6][7]. - Suzuki collaborated with Professor Ando to develop the C9920-02 prototype, integrating a multi-channel spectrometer with an integrating sphere for solid material measurement [8]. Group 3: Market Expansion - The launch of the compact device Quantaurus-QY significantly improved operational convenience and system stability, facilitating its application in the emerging Chinese market for luminescent materials [17]. - A localized service system was established to address challenges in promoting the device in China, enhancing customer trust and understanding of its advantages over traditional methods [18][19]. Group 4: Demand-Driven Innovation - The complexity of luminescent materials led to a heightened demand for measuring upconversion materials, which traditional systems could not meet [21][23]. - The development of Quantaurus-QY PLUS was driven by clear and urgent demands from Chinese researchers, successfully addressing the measurement challenges of upconversion materials [24]. Group 5: Continuous Evolution - The timeline of the Quantaurus series illustrates the product lifecycle, with continuous innovations driven by user needs, including the development of OPAL-Luxe and MINI-PL for next-generation display materials [26][31]. - The rigorous validation process for the C9920-02 system involved extensive testing and cross-verification, culminating in significant academic publications that established its reliability [27][28]. Group 6: Legacy and Future Empowerment - The Quantaurus series has become a standard in over 3,000 laboratories globally, reflecting its impact on the transition from fundamental research to industrial application [30]. - Future developments are focused on higher precision measurement solutions for new luminescent materials, indicating ongoing commitment to innovation in the field [31].

Summary of Wanyi Technology Conference Call Company Overview - Wanyi Technology is undergoing a strategic transformation from traditional industrial environmental products to the semiconductor and industrial sectors, while actively developing medical instruments such as ultrasonic scalpels and blood dialysis machines, with the ultrasonic scalpel already entering centralized procurement, showcasing its potential for diversified development [2][3][4] Key Business Segments - The company has four main product lines: 1. **Industrial Intelligent Products**: Includes helium mass spectrometers, airtightness testers, and vacuum leak detection systems, primarily focused on the new energy sector and expanding into semiconductors [3] 2. **Industrial Environmental Products**: Focuses on environmental monitoring, transitioning towards semiconductor and industrial applications [3] 3. **Analytical Instruments**: Offers a comprehensive product line in the domestic market, including ion chromatography, gas chromatography, and liquid chromatography, serving universities, research institutions, and the food and agriculture sectors [3] 4. **Medical Instruments**: Developing blood dialysis machines and ultrasonic scalpels, with the latter having received Class III medical device certification and entering centralized procurement in 15 provinces [3][4] Strategic Focus and Market Position - Wanyi Technology positions itself in the mid-to-high-end market, benchmarking against international advanced products through technological innovation and performance enhancement, particularly in the gas analysis instrument market [4] - The company is increasing R&D investment, especially in liquid chromatography, to meet the growing domestic demand for localized alternatives in the analytical instrument market due to geopolitical influences [2][16] Semiconductor Sector Developments - The helium mass spectrometer is widely used in semiconductor manufacturing processes, including single crystal furnace pipelines, CVD, PVD, and plasma etching [12] - The company is developing gas analyzers for monitoring residual gas components during CVD and PVD processes to ensure chip quality [12] - Domestic companies like Changxin Storage and Yangtze Memory Technologies are increasingly adopting domestic equipment, achieving over 50% localization in manufacturing data collection [14] Nuclear Fusion Sector Contributions - Wanyi Technology provides high-precision vacuum leak detection solutions critical for the construction of nuclear fusion devices, with helium mass spectrometers being a core product [5][8] - The company occupies approximately 2%-3% of the cost structure in nuclear fusion reactors, contributing to various key systems including vacuum, raw material, thermal management, and measurement systems [8][10] - The company is actively involved in the Hefei Fusion Industry Alliance, enhancing its role as a key supplier in the nuclear fusion sector [10][11] Medical Device Market Insights - The ultrasonic scalpel market is estimated to be around 5-6 billion yuan, with a significant reliance on imports. Wanyi Technology aims to capture market share by offering competitively priced products [24] - The blood dialysis equipment market is projected to reach 10 billion yuan by 2025-2026, with the company expecting to launch its product by the end of 2026 [25][26] R&D and Future Outlook - Wanyi Technology maintains a high R&D investment, allocating about 20% of its revenue annually to R&D, with plans to stabilize this at around 15% in the future [27] - The company is optimistic about its prospects in the laboratory precision instrument sector, supported by favorable national policies and increasing domestic demand [23] Sales Strategy Adjustments - The company has shifted its sales model from relying on agents to a direct sales approach, enhancing customer engagement and improving gross margins [18] Conclusion - Wanyi Technology is strategically positioned to leverage its technological advancements and market opportunities across various sectors, including semiconductors, nuclear fusion, and medical devices, while maintaining a strong focus on R&D and market localization efforts [30]